Human Fear Acquisition Deficits in Relation to Genetic Variants of the Corticotropin Releasing Hormone Receptor 1 and the Serotonin Transporter

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Heitland, Ivo ^a,b   Groenink, Lucianne ^c   Bijlsma, Elisabeth Y ^c   Oosting, Ronald S ^c   Baas, Johanna M P ^a,b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; SEROTONIN TRANSPORTER;

5HTTLPR GENE; ADULT; ARTICLE; CONDITIONED REFLEX; CRHR1 GENE; EYELID REFLEX; FEAR; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PROTEIN PROTEIN INTERACTION;

ADULT; ALLELES; ANXIETY DISORDERS; CONDITIONING, CLASSICAL; FEAR; FEMALE; GENOTYPE; HUMANS; MALE; POLYMORPHISM, GENETIC; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; REFLEX; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; YOUNG ADULT;

EID: 84878075052     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063772     Document Type: Article

References (64)

1. Mineka S, Zinbarg R, (1996) Conditioning and ethological models of anxiety disorders: stress-in-dynamic-context anxiety models. Nebr Symp Motiv 43: 135-210.
2. Mineka S, Oehlberg K, (2008) The relevance of recent developments in classical conditioning to understanding the etiology and maintenance of anxiety disorders. Acta Psychol (Amst) 127: 567-580.
3. Grillon C, (2002) Associative learning deficits increase symptoms of anxiety in humans. Biol Psychiatry 51: 851-858.
4. Baas JM, van Ooijen L, Goudriaan A, Kenemans JL, (2008) Failure to condition to a cue is associated with sustained contextual fear. Acta Psychol (Amst) 127: 581-592.
5. Wolpe J, Rowan VC, (1988) Panic disorder: a product of classical conditioning. Behav Res Ther 26: 441-450.
6. Baas JM, (2013) Individual differences in predicting aversive events and modulating contextual anxiety in a context and cue conditioning paradigm. Biological psychology 92: 17-25.
7. Hettema JM, Neale MC, Kendler KS, (2001) A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry 158: 1568-1578.
8. Hettema JM, Annas P, Neale MC, Kendler KS, Fredrikson M, (2003) A twin study of the genetics of fear conditioning. Arch Gen Psychiatry 60: 702-708.
9. Lonsdorf TB, Kalisch R, (2011) A review on experimental and clinical genetic associations studies on fear conditioning, extinction and cognitive-behavioral treatment. Transl Psychiatry 1: e41.
10. Heils A, Teufel A, Petri S, Stober G, Riederer P, et al. (1996) Allelic variation of human serotonin transporter gene expression. J Neurochem 66: 2621-2624.
11. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, et al. (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274: 1527-1531.
12. Munafò MR, Freimer NB, Ng W, Ophoff R, Veijola J, et al. (2009) 5-HTTLPR genotype and anxiety-related personality traits: a meta-analysis and new data. Am J Med Genet B Neuropsychiatr Genet 150B: 271-281.
13. Schinka JA, Busch RM, Robichaux-Keene N, (2004) A meta-analysis of the association between the serotonin transporter gene polymorphism (5-HTTLPR) and trait anxiety. Mol Psychiatry 9: 197-202.
14. Sen S, Burmeister M, Ghosh D, (2004) Meta-analysis of the association between a serotonin transporter promoter polymorphism (5-HTTLPR) and anxiety-related personality traits. Am J Med Genet B Neuropsychiatr Genet 127B: 85-89.
15. Garpenstrand H, Annas P, Ekblom J, Oreland L, Fredrikson M, (2001) Human fear conditioning is related to dopaminergic and serotonergic biological markers. Behav Neurosci 115: 358-364.
16. Davis M, (2006) Neural systems involved in fear and anxiety measured with fear-potentiated startle. Am Psychol 61: 741-756.
17. Grillon C, Baas J, (2003) A review of the modulation of the startle reflex by affective states and its application in psychiatry. Clin Neurophysiol 114: 1557-1579.
18. Lang PJ, Davis M, Ohman A, (2000) Fear and anxiety: animal models and human cognitive psychophysiology. J Affect Disord 61: 137-159.
19. Norrholm SD, Jovanovic T, Vervliet B, Myers KM, Davis M, et al. (2006) Conditioned fear extinction and reinstatement in a human fear-potentiated startle paradigm. Learn Mem 13: 681-685.
20. Lonsdorf TB, Weike AI, Nikamo P, Schalling M, Hamm AO, et al. (2009) Genetic gating of human fear learning and extinction: possible implications for gene-environment interaction in anxiety disorder. Psychological Science 20: 198-206.
21. Klumpers F, Heitland I, Oosting RS, Kenemans JL, Baas JM, (2012) Genetic variation in serotonin transporter function affects human fear expression indexed by fear-potentiated startle. Biol Psychol 89: 277-282.
22. Lowry CA, Moore FL, (2006) Regulation of behavioral responses by corticotropin-releasing factor. Gen Comp Endocrinol 146: 19-27.
23. Hauger RL, Risbrough V, Brauns O, Dautzenberg FM, (2006) Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets. CNS Neurol Disord Drug Targets 5: 453-479.
24. Hauger RL, Risbrough V, Oakley RH, Olivares-Reyes JA, Dautzenberg FM, (2009) Role of CRF receptor signaling in stress vulnerability, anxiety, and depression. Ann N Y Acad Sci 1179: 120-143.
25. Bijlsma EY, van Leeuwen ML, Westphal KG, Olivier B, Groenink L, (2011) Local repeated corticotropin-releasing factor infusion exacerbates anxiety- and fear-related behavior: differential involvement of the basolateral amygdala and medial prefrontal cortex. Neuroscience 173: 82-92.
26. Risbrough VB, Geyer MA, Hauger RL, Coste S, Stenzel-Poore M, et al. (2009) CRF1 and CRF2 receptors are required for potentiated startle to contextual but not discrete cues. Neuropsychopharmacology 34: 1494-1503.
27. Roozendaal B, Schelling G, McGaugh JL, (2008) Corticotropin-releasing factor in the basolateral amygdala enhances memory consolidation via an interaction with the beta-adrenoceptor-cAMP pathway: dependence on glucocorticoid receptor activation. J Neurosci 28: 6642-6651.
28. Binder EB, Nemeroff CB, (2010) The CRF system, stress, depression and anxiety-insights from human genetic studies. Mol Psychiatry 15: 574-588.
29. Smoller JW, Gardner-Schuster E, Covino J, (2008) The genetic basis of panic and phobic anxiety disorders. Am J Med Genet C Semin Med Genet 148C: 118-126.
30. Keck ME, Kern N, Erhardt A, Unschuld PG, Ising M, et al. (2008) Combined effects of exonic polymorphisms in CRHR1 and AVPR1B genes in a case/control study for panic disorder. Am J Med Genet B Neuropsychiatr Genet 147B: 1196-1204.
31. Holsboer F, Ising M, (2008) Central CRH system in depression and anxiety-evidence from clinical studies with CRH1 receptor antagonists. Eur J Pharmacol 583: 350-357.
32. Steckler T, Dautzenberg FM, (2006) Corticotropin-releasing factor receptor antagonists in affective disorders and drug dependence- an update. CNS Neurol Disord Drug Targets 5: 147-165.
33. Lukkes J, Vuong S, Scholl J, Oliver H, Forster G, (2009) Corticotropin-releasing factor receptor antagonism within the dorsal raphe nucleus reduces social anxiety-like behavior after early-life social isolation. J Neurosci 29: 9955-9960.
34. Valentino RJ, Lucki I, Van Bockstaele E, (2010) Corticotropin-releasing factor in the dorsal raphe nucleus: Linking stress coping and addiction. Brain Res 1314: 29-37.
35. Cicchetti D, Rogosch FA, Oshri A, (2011) Interactive effects of corticotropin releasing hormone receptor 1, serotonin transporter linked polymorphic region, and child maltreatment on diurnal cortisol regulation and internalizing symptomatology. Dev Psychopathol 23: 1125-1138.
36. Ressler KJ, Bradley B, Mercer KB, Deveau TC, Smith AK, et al. (2010) Polymorphisms in CRHR1 and the serotonin transporter loci: gene x gene x environment interactions on depressive symptoms. Am J Med Genet B Neuropsychiatr Genet 153B: 812-824.
37. Bijlsma EY, Gool JM, Baas JMP, Olivier B, Groenink L (2012) Lifelong, but not acute or chronic, inactivation of the serotonin transporter hampers fear learning in rat fear-potentiated startle. Program No20109/BBB32 Neuroscience Meeting Planner New Orleans, LA: Society for Neuroscience, 2012 Online.
38. Heitland I, Klumpers F, Oosting RS, Evers DJ, Leon Kenemans J, et al. (2012) Failure to extinguish fear and genetic variability in the human cannabinoid receptor 1. Translational psychiatry 2: e162.
39. Baas JM, Nugent M, Lissek S, Pine DS, Grillon C, (2004) Fear conditioning in virtual reality contexts: a new tool for the study of anxiety. Biol Psychiatry 55: 1056-1060.
40. Klumpers F, Raemaekers MA, Ruigrok AN, Hermans EJ, Kenemans JL, et al. (2010) Prefrontal mechanisms of fear reduction after threat offset. Biol Psychiatry 68: 1031-1038.
41. Klumpers F, van Gerven JM, Prinssen EP, Niklson I, Roesch F, et al. (2010) Method development studies for repeatedly measuring anxiolytic drug effects in healthy humans. J Psychopharmacol 24: 657-666.
42. Blumenthal TD, Cuthbert BN, Filion DL, Hackley S, Lipp OV, et al. (2005) Committee report: Guidelines for human startle eyeblink electromyographic studies. Psychophysiology 42: 1-15.
43. Bocker KB, Baas JM, Kenemans JL, Verbaten MN, (2004) Differences in startle modulation during instructed threat and selective attention. Biol Psychol 67: 343-358.
44. Costa PT, McCrae RR (1992) NEO-PI-R Professional Manual. Psychological Assessment Resources, Odessa, FL.
45. Lonsdorf TB, Ruck C, Bergstrom J, Andersson G, Ohman A, et al. (2009) The symptomatic profile of panic disorder is shaped by the 5-HTTLPR polymorphism. Prog Neuropsychopharmacol Biol Psychiatry 33: 1479-1483.
46. Heitland I, Oosting RS, Baas JM, Massar SA, Kenemans JL, et al. (2012) Genetic polymorphisms of the dopamine and serotonin systems modulate the neurophysiological response to feedback and risk taking in healthy humans. Cognitive, affective & behavioral neuroscience 12: 678-691.
47. Liang KC, Lee EH, (1988) Intra-amygdala injections of corticotropin releasing factor facilitate inhibitory avoidance learning and reduce exploratory behavior in rats. Psychopharmacology (Berl) 96: 232-236.
48. Roozendaal B, Brunson KL, Holloway BL, McGaugh JL, Baram TZ, (2002) Involvement of stress-released corticotropin-releasing hormone in the basolateral amygdala in regulating memory consolidation. Proc Natl Acad Sci U S A 99: 13908-13913.
49. Bouton ME, Mineka S, Barlow DH, (2001) A modern learning theory perspective on the etiology of panic disorder. Psychol Rev 108: 4-32.
50. Lissek S, Powers AS, McClure EB, Phelps EA, Woldehawariat G, et al. (2005) Classical fear conditioning in the anxiety disorders: a meta-analysis. Behav Res Ther 43: 1391-1424.
51. Armbruster D, Moser DA, Strobel A, Hensch T, Kirschbaum C, et al. (2009) Serotonin transporter gene variation and stressful life events impact processing of fear and anxiety. Int J Neuropsychopharmacol 12: 393-401.
52. Brocke B, Armbruster D, Muller J, Hensch T, Jacob CP, et al. (2006) Serotonin transporter gene variation impacts innate fear processing: Acoustic startle response and emotional startle. Mol Psychiatry 11: 1106-1112.
53. Larson CL, Taubitz LE, Robinson JS, (2010) MAOA T941G polymorphism and the time course of emotional recovery following unpleasant pictures. Psychophysiology 47: 857-862.
54. Pauli P, Conzelmann A, Mucha RF, Weyers P, Baehne CG, et al. (2010) Affect-modulated startle reflex and dopamine D4 receptor gene variation. Psychophysiology 47: 25-33.
55. Hermann A, Kupper Y, Schmitz A, Walter B, Vaitl D, et al. (2012) Functional gene polymorphisms in the serotonin system and traumatic life events modulate the neural basis of fear acquisition and extinction. PLoS One 7: e44352.
56. Klucken T, Alexander N, Schweckendiek J, Merz CJ, Kagerer S, et al. (2012) Individual differences in neural correlates of fear conditioning as a function of 5-HTTLPR and stressful life events. Soc Cogn Affect Neurosci.
57. Crisan LG, Pana S, Vulturar R, Heilman RM, Szekely R, et al. (2009) Genetic contributions of the serotonin transporter to social learning of fear and economic decision making. Soc Cogn Affect Neurosci 4: 399-408.
58. Grillon C, Baas JM, Pine DS, Lissek S, Lawley M, et al. (2006) The benzodiazepine alprazolam dissociates contextual fear from cued fear in humans as assessed by fear-potentiated startle. Biol Psychiatry 60: 760-766.
59. Kindt M, Soeter M, Vervliet B, (2009) Beyond extinction: erasing human fear responses and preventing the return of fear. Nat Neurosci 12: 256-258.
60. Meyer-Lindenberg A, (2012) The future of fMRI and genetics research. NeuroImage 62: 1286-1292.
61. Kraft JB, Slager SL, McGrath PJ, Hamilton SP, (2005) Sequence analysis of the serotonin transporter and associations with antidepressant response. Biol Psychiatry 58: 374-381.
62. Hu XZ, Lipsky RH, Zhu G, Akhtar LA, Taubman J, et al. (2006) Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet 78: 815-826.
63. Holloway JL, Beck KD, Servatius RJ, (2011) Facilitated acquisition of the classically conditioned eyeblink response in females is augmented in those taking oral contraceptives. Behav Brain Res 216: 301-307.
64. Milad MR, Goldstein JM, Orr SP, Wedig MM, Klibanski A, et al. (2006) Fear conditioning and extinction: influence of sex and menstrual cycle in healthy humans. Behav Neurosci 120: 1196-1203.